7
Views
34
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Glycogen Synthase Kinase 3 Phosphorylates RBL2/p130 during Quiescence

, &
Pages 8970-8980 | Received 11 May 2004, Accepted 22 Jul 2004, Published online: 27 Mar 2023

REFERENCES

  • Ausubel, F. M. (ed.). 1999. Short protocols in molecular biology, 4th ed. John Wiley & Sons, Inc., New York, N.Y.
  • Bhattacharya, S., Garriga J., Calbo J., Yong T., Haines D. S., and Grana X.. 2003. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22:2443–2451.
  • Cam, H., and Dynlacht B. D.. 2003. Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3:311–316.
  • Canhoto, A. J., Chestukhin A., Litovchick L., and DeCaprio J. A.. 2000. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells. Oncogene 19:5116–5122.
  • Chestukhin, A., Litovchick L., Rudich K., and DeCaprio J. A.. 2002. Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism. Mol. Cell. Biol. 22:453–468.
  • Classon, M., and Dyson N.. 2001. p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264:135–147.
  • Classon, M., Salama S., Gorka C., Mulloy R., Braun P., and Harlow E.. 2000. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc. Natl. Acad. Sci. USA 97:10820–10825.
  • Cobrinik, D., Lee M. H., Hannon G., Mulligan G., Bronson R. T., Dyson N., Harlow E., Beach D., Weinberg R. A., and Jacks T.. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10:1633–1644.
  • Coghlan, M. P., Culbert A. A., Cross D. A., Corcoran S. L., Yates J. W., Pearce N. J., Rausch O. L., Murphy G. J., Carter P. S., Roxbee Cox L., Mills D., Brown M. J., Haigh D., Ward R. W., Smith D. G., Murray K. J., Reith A. D., and Holder J. C.. 2000. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7:793–803.
  • Dajani, R., Fraser E., Roe S. M., Young N., Good V., Dale T. C., and Pearl L. H.. 2001. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:721–732.
  • Dannenberg, J. H., van Rossum A., Schuijff L., and te Riele H.. 2000. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14:3051–3064.
  • Davies, S. P., Reddy H., Caivano M., and Cohen P.. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95–105.
  • Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553–14556.
  • DeCaprio, J. A., Ludlow J. W., Figge J., Shew J. Y., Huang C. M., Lee W. H., Marsilio E., Paucha E., and Livingston D. M.. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–283.
  • Dick, F. A., Sailhamer E., and Dyson N. J.. 2000. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20:3715–3727.
  • Diehl, J. A., Cheng M., Roussel M. F., and Sherr C. J.. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499–3511.
  • Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
  • Dyson, N., Buchkovich K., Whyte P., and Harlow E.. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58:249–255.
  • Farkas, T., Hansen K., Holm K., Lukas J., and Bartek J.. 2002. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F4. J. Biol. Chem. 277:26741–26752.
  • Ferkey, D. M., and Kimelman D.. 2000. GSK3: new thoughts on an old enzyme. Dev. Biol. 225:471–479.
  • Frame, S., Cohen P., and Biondi R. M.. 2001. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7:1321–1327.
  • Garriga, J., Limon A., Mayol X., Rane S. G., Albrecht J. H., Reddy E. P., Andres V., and Grana X.. 1998. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem. J. 333:645–654.
  • Ghosh, M. K., and Harter M. L.. 2003. A viral mechanism for remodeling chromatin structure in G0 cells. Mol. Cell 12:255–260.
  • Graña, X., Garriga J., and Mayol X.. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365–3383.
  • Hahn, W. C., Counter C. M., Lundberg A. S., Beijersbergen R. L., Brooks M. W., and Weinberg R. A.. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464–468.
  • Hansen, K., Farkas T., Lukas J., Holm K., Ronnstrand L., and Bartek J.. 2001. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block. EMBO J. 20:422–432.
  • Hansen, K., Lukas J., Holm K., Kjerulff A. A., and Bartek J.. 1999. Dissecting functions of the retinoblastoma tumor suppressor and the related pocket proteins by integrating genetic, cell biology, and electrophoretic techniques. Electrophoresis 20:372–381.
  • Harwood, A. J. 2001. Regulation of GSK3: a cellular multiprocessor. Cell 105:821–824.
  • Herrera, R. E., Sah V. P., Williams B. O., Mäkelä T. P., Weinberg R. A., and Jacks T.. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402–2407.
  • Lacy, S., and Whyte P.. 1997. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene 14:2395–2406.
  • LeCouter, J. E., Kablar B., Hardy W. R., Ying C., Megeney L. A., May L. L., and Rudnicki M. A.. 1998. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol. Cell. Biol. 18:7455–7465.
  • LeCouter, J. E., Kablar B., Whyte P. F., Ying C., and Rudnicki M. A.. 1998. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125:4669–4679.
  • Lee, D. H., and Goldberg A. L.. 1996. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271:27280–27284.
  • Lee, M. H., Williams B. O., Mulligan G., Mukai S., Bronson R. T., Dyson N., Harlow E., and Jacks T.. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10:1621–1632.
  • Li, Y., Graham C., Lacy S., Duncan A. M., and Whyte P.. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366–2377.
  • Lipinski, M. M., and Jacks T.. 1999. The retinoblastoma gene family in differentiation and development. Oncogene 18:7873–7882.
  • Mayol, X., Garriga J., and Graña X.. 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11:801–808.
  • Mayol, X., Garriga J., and Graña X.. 1996. G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F4. Oncogene 13:237–246.
  • Morgenstern, J. P., and Land H.. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596.
  • Mulligan, G., and Jacks T.. 1998. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14:223–229.
  • Naerum, L., Norskov-Lauritsen L., and Olesen P. H.. 2002. Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. Bioorg. Med. Chem. Lett. 12:1525–1528.
  • Pear, W. S., Nolan G. P., Scott M. L., and Baltimore D.. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
  • Plyte, S. E., Hughes K., Nikolakaki E., Pulverer B. J., and Woodgett J. R.. 1992. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114:147–162.
  • Reynolds, C. H., Betts J. C., Blackstock W. P., Nebreda A. R., and Anderton B. H.. 2000. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J. Neurochem. 74:1587–1595.
  • Rossi, F., MacLean H. E., Yuan W., Francis R. O., Semenova E., Lin C. S., Kronenberg H. M., and Cobrinik D.. 2002. p107 and p130 coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev. Biol. 247:271–285.
  • Ruiz, S., Segrelles C., Bravo A., Santos M., Perez P., Leis H., Jorcano J. L., and Paramio J. M.. 2003. Abnormal epidermal differentiation and impaired epithelial-mesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130. Development 130:2341–2353.
  • Ryves, W. J., and Harwood A. J.. 2001. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280:720–725.
  • Sage, J., Mulligan G. J., Attardi L. D., Miller A., Chen S., Williams B., Theodorou E., and Jacks T.. 2000. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:3037–3050.
  • Salic, A., Lee E., Mayer L., and Kirschner M. W.. 2000. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol. Cell 5:523–532.
  • Sears, R., Nuckolls F., Haura E., Taya Y., Tamai K., and Nevins J. R.. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2501–2514.
  • Smith, E. J., Leone G., DeGregori J., Jakoi L., and Nevins J. R.. 1996. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell. Biol. 16:6965–6976.
  • Smith, E. J., Leone G., and Nevins J. R.. 1998. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ. 9:297–303.
  • Stevaux, O., and Dyson N. J.. 2002. A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14:684–691.
  • Tedesco, D., Lukas J., and Reed S. I.. 2002. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 16:2946–2957.
  • ter Haar, E., Coll J. T., Austen D. A., Hsiao H. M., Swenson L., and Jain J.. 2001. Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8:593–596.
  • Whyte, P., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., and Harlow E.. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124–129.
  • Woodgett, J. R. 2001. Judging a protein by more than its name: GSK3. Sci. STKE 2001:RE12. [Online.] http://stke.sciencemag.org.
  • Yamamoto, H., Kishida S., Kishida M., Ikeda S., Takada S., and Kikuchi A.. 1999. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J. Biol. Chem. 274:10681–10684.
  • Zalvide, J., and DeCaprio J. A.. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800–5810.
  • Zhang, S., Qian X., Redman C., Bliskovski V., Ramsay E. S., Lowy D. R., and Mock B. A.. 2003. p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 22:2285–2295.
  • Zhang, S., Ramsay E. S., and Mock B. A.. 1998. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl. Acad. Sci. USA 95:2429–2434.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.